{"schema_version":"secwatch.filing_event.v1","accession":"0001654954-25-000919","form_type":"8-K","ticker":"PBSV","cik":"0001304161","company_name":"Pharma-Bio Serv, Inc.","filed_at":"2025-01-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.251431+00:00","generated_at":"2026-05-27T06:35:24.430392+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Pharma-Bio Serv FY2024 rev $9.5M (-$7.5M YoY), net loss $0.8M; declares $0.075 special dividend","bullets":["Revenue for year ended Oct 31, 2024 approximately $9.5M, a decrease of $7.5M from prior year.","Net loss of approximately $0.8M compared to net income of $1.3M in the prior year.","Board approved a Special Dividend of $0.075 per share payable on or about March 20, 2025.","CEO cited challenging industry conditions in 2024; focused on higher-value services and new technologies."],"urls":{"canonical":"https://secwatch.observer/filing/0001654954-25-000919","json":"https://secwatch.observer/filing/0001654954-25-000919.json","markdown":"https://secwatch.observer/filing/0001654954-25-000919.md","text":"https://secwatch.observer/filing/0001654954-25-000919.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1304161/000165495425000919/0001654954-25-000919-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1304161/000165495425000919/pbsv_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-27T06:35:24.430392+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}